Akebia Therapeutics Inc. (AKBA) Slipped -13.04% or -1.05 To Price $7.0 On Tuesday
Akebia Therapeutics Inc. (AKBA) slipped -13.04% or -1.05 to $7.0. It is nearly 2.56 million shares traded, which is 180.86% compare to the average total volume 1.41 million. The market cap of AKBA is $819.86 million. The year to date…